Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Jersey for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Jersey only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Jersey (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Glen Gejerman (NPI 1972565182)

Field	Value
Entity Type	Individual
Organization	Glen Gejerman
Address	92 2nd St
City	Hackensack
State	NJ
ZIP	07601
Taxonomy	Radiation Oncology Physician
NPI Enumerated	April 4, 2006

Payer Source	Total Paid
Medicare	$6.5M
Medicaid	$0

Key Findings

Practice profile and scale: GLEN GEJERMAN is enumerated as a Radiation Oncology Physician in HACKENSACK, NJ with total Medicare revenue of $6.5M and no Medicaid billing on file (none below). The NPI was registered on 2006-04-04 (~20 years ago), indicating a long-tenured Medicare billing history and an established clinical presence in the market.

Revenue concentration: This provider’s Medicare income is heavily concentrated in a few codes — the precomputed top three codes account for 67.3% of total Medicare revenue. The top three contributors are A9607 ($2M, 30.4%), G6015 ($1.4M, 21.6%), and A9606 ($993.7K, 15.3%), signaling that most revenue comes from high-cost radiopharmaceuticals and advanced radiation delivery services.

Service-line implications — radiopharmaceuticals and advanced external beam therapy: The mix is dominated by therapeutic radiopharmaceutical codes (A9607 and A9606) and a high-volume intensity-modulated delivery code (G6015). This pattern, together with sizeable revenues reported for planning and IMRT-related codes such as 77301 ($436K, 6.7%) and 77338 ($87.2K, 1.3%), points to a practice that delivers both specialty radionuclide treatments and a high-throughput IMRT radiation therapy program rather than a generalist outpatient clinic.

Competitive standing by code — national leadership in several high-volume procedures: G6015 is an outlier nationally (ranks #12 of 1429, 99th percentile; labeled "extreme outlier"), indicating this provider is a major national-level deliverer of that specific IMRT service. Similarly, 55874 ($544.8K, 8.4%) ranks #1 of 557 providers (100th percentile; "extreme outlier"), marking top national volume for prostate spacer placement and distinguishing the provider in that niche.

Mixed strength across radiopharmaceuticals: For radiopharmaceuticals the standing is more variable — A9607 ($2M, 30.4%) ranks #12 of 44 (74th percentile; "typical, unremarkable volume") while A9606 ($993.7K, 15.3%) ranks #2 of 6 (80th percentile; "typical, unremarkable volume"). This suggests meaningful activity in radionuclide therapeutics but not uniformly dominant market share across every radiopharmaceutical product.

High-volume planning and delivery footprint: Multiple radiation planning and delivery codes show extreme national percentiles (for example, 77014 $454.2K, 7.0%, ranks #14 of 4303 providers, 100th percentile, "extreme outlier"; 77301 $436K, 6.7%, ranks #9 of 3815, 100th percentile, "extreme outlier"). Those high-percentile placements across imaging, planning, and delivery codes indicate integrated capabilities and high throughput across the care pathway for radiation oncology.

Single-payer concentration and business risk: The provider is effectively single-payer with Medicare revenue of $6.5M and no Medicaid billing on file (none below). That payer concentration should be considered when assessing revenue sustainability and sensitivity to Medicare policy or reimbursement changes, since there is no Medicaid revenue to diversify payer mix.

Analytic flags and review priorities: Many codes are explicitly labeled as "extreme outlier" or "notably above typical" (e.g., G6015, 55874, 77014, 77301, 77336, 77338, 77427), which in payer analytics would reasonably prioritize focused clinical-appropriateness and coding-pattern reviews for those services. These labels describe statistical standing relative to peers and, combined with dollar concentrations, identify where to prioritize audit or utilization management attention without implying improper conduct.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

34 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
A9607	Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie	11,010	$180	$2M
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	4,350	$320	$1.4M
A9606	Radium ra-223 dichloride, therapeutic, per microcurie	7,700	$130	$993.7K
55874	Under imaging guidance, the provider inserts a needle through the perineum, the area between the anus and the scrotum, and injects one or more biodegradable materials, i.e., material that decomposes…	220	$2,440	$544.8K
77014	N/A	4,290	$110	$454.2K
77301	Intensity modulated radiotherapy (IMRT) uses advanced computer technology to deliver very precise radiation beams that target and destroy the cancerous cells while avoiding the surrounding healthy…	270	$1,630	$436K
77427	Radiation therapy utilizes ionizing radiation beams that are directed at cancerous cells in order to destroy them. The radiation, damages the DNA (the genetic material) in the cell, thus preventing…	1,040	$160	$165.7K
77338	In this procedure, the provider participates in the design and construction of one or more multi–leaf collimator, MLC, devices for intensity modulated radiation therapy, IMRT. IMRT is a radiotherapy…	220	$400	$87.2K
77336	This code is for reporting ongoing medical physics consultation. When a patient is undergoing radiation treatment for a particular span of time with a number of therapy sessions every week, the…	1,050	$80	$80.8K
J0897	Injection, denosumab, 1 mg	3,300	$20	$59.4K

Showing 1–10 of 34

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 34 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Jersey Distribution

Glen Gejerman — 14 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Jersey

Full comparison — all codes billed, vs. state median

34 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
A9606	1	10	7,700	$130	$992.2K
A9607	1	10	5,530	$180	$990.5K
G6015	1	30	880	$320	$381.1K
J0897	171	380	3,060	$20	$87.8K
55874	1	10	20	$1,590	$70.2K
77014	1	100	580	$70	$52.4K
77427	2	110	210	$160	$41.3K
G6013	7	10	130	$220	$37.3K
77301	1	80	40	$730	$34.8K
77336	1	30	200	$80	$22.5K

Showing 1–10 of 34

Related Providers

Other providers that share a Tax Identification Number (TIN) with Glen Gejerman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
City Medical Of Upper East Side, PLLC	NY	Urgent Care Clinic/Center	$0	$641.6M
Summit Medical Group, Inc	KY	Family Medicine Physician	$0	$95.1M
Bhavesh Balar	NJ	Hematology & Oncology Physician	$4.2M	$0
Bader Pedemonte	NJ	Hematology (Pathology) Physician	$4.2M	$1.5K
Kenneth Nahum	NJ	Hematology & Oncology Physician	$3.2M	$0
Elizabeth Fleming	NJ	Adult Health Nurse Practitioner	$2.9M	$0
Frederick Smith	MD	Medical Oncology Physician	$2.7M	$0
May Abdo-matkiwsky	NJ	Hematology & Oncology Physician	$2.6M	$0
John Sylvester	FL	Radiation Oncology Physician	$2.5M	$0
Denis Fitzgerald	NJ	Hematology & Oncology Physician	$2.3M	$0

Nearby Providers

Other providers in the same ZIP code as Glen Gejerman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Care Finders Total Care LLC	NJ	Home Health Agency	$0	$710M
Hmh Hospitals Corporation	NJ	General Acute Care Hospital	$0	$333.3M
Confident Care Corp	NJ	Nursing Care Agency	$0	$115.1M
Bergen's Promise, Inc.	NJ	Case Management Agency	$0	$91.3M
The Center For Family Support, New Jersey, Inc.	NJ	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$76.6M
The Arc Of Bergen And Passaic Counties, Inc.	NJ	Community/Behavioral Health Agency	$0	$68.2M
Loving Care Agency, Inc	NJ	Home Health Agency	$0	$59.1M
Comprehensive Behavioral Healthcare, Inc.	NJ	Respite Care	$0	$48.2M
Alpha Care Home Health Services Of Nj, Inc.	NJ	Home Health Agency	$0	$28.2M
Eastern Nursing Services I, Inc	NJ	Home Health Agency	$0	$23M

Glen Gejerman — Billing Profile & Reimbursement Data

Sign up for Glen Gejerman — Billing Profile & Reimbursement Data policy alerts

Glen Gejerman — Billing Profile & Reimbursement Data

Sign up for Glen Gejerman — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References